Last reviewed · How we verify
NCT07320469
Efficacy of Inspiratory Muscle Trainers on Patients With Obesity and LowBack Pain
NA trial testing Inspiratory muscle trainer in Obesity in 48 participants. Not yet recruiting.
30 August 2026
Quick facts
| Lead sponsor | Imam Abdulrahman Bin Faisal University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | diagnostic |
| Enrollment | 48 |
| Start date | 1 March 2026 |
| Primary completion | 30 August 2026 |
| Estimated completion | 30 August 2026 |
Drugs / interventions tested
- Inspiratory muscle trainer
Conditions studied
- Obesity — all drugs for Obesity →
- Low Back Pain — all drugs for Low Back Pain →
Sponsor
Imam Abdulrahman Bin Faisal University
Who can join
Adults 20 to 55, any sex, with Obesity or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Obesity and mechanical low back pain (MLBP) are two major health problems negatively affecting the human body. Many studies have shown that obesity and MLBP are associated with negative effects on the respiratory system. There are many interventions to treat obesity and MLBP, such as aerobic exercise and diet programs. Moreover, the Inspiratory Muscle Trainer (IMT) significantly improved inspiratory muscle strength in patients with obesity. This study aims to investigate whether adding IMT to aerobic exercise will improve respiratory function, exercise capacity, and pain intensity in patients with obesity and MLBP. Materials and Methods: A total of forty-eight obese patients with MLBP will be equally and randomly assigned to the experimental group and control group. The experimental group will have training on IMT for 6 weeks, three days per week (two sessions daily, thirty breaths per session) using POWERbreathe IMT, starting at 40% of maximal inspiratory pressure with increasing training load at the third week, in addition to having aerobic exercise three times a week for 30 minutes and total body resistance. The control group will have the same training as the experimental group, except for IMT; they will have zero resistance. Main outcome measures: pulmonary function tests and maximal inspiratory pressures to assess respiratory function; VO2 to assess exercise capacity; pain intensity; and Oswestry Disability Index to determine functional disability. All the measurements will be done before and after the intervention in both groups. Paired and independent t-tests will be used to compare within- and between-group differences. A repeated-measures design will be used to determine significant differences before, during, and after the intervention within each group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07320469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Inspiratory muscle trainer
Trials testing the same drug.
- NCT07367945 — Incentive Spirometry Versus Inspiratory Muscle Training After Coronary Artery Bypass Grafting · NA · not yet recruiting
- NCT04919031 — Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms · NA · completed
- NCT03887546 — Inspiratory Muscle Training in Multiple Sclerosis · NA · unknown
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Imam Abdulrahman Bin Faisal University trials
Trials by the same sponsor.
- NCT07326956 — Efficacy of Core Stability Training on Endurance, Kinetic Chain Function, and Dynamic Balance in Soccer Players · NA · not yet recruiting
- NCT06844825 — Telerehabilitation in Managing Chronic Low Back Pain · NA · not yet recruiting
- NCT06842485 — Effectiveness of Telerehabilitation for Work-Related Musculoskeletal Disorders in Cardiac Sonographers · NA · completed
- NCT06704880 — CONSTRAINT-INDUCED MOVEMENT THERAPY VERSUS CROSS EDUCATION IN CHILDREN WITH CEREBRAL PALSY · NA · not yet recruiting
- NCT06960525 — Joint Mobilization vs. Strengthening Exercises on Cervical Proprioception for Nonspecific Neck Pain · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07320469 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Imam Abdulrahman Bin Faisal University
- Last refreshed: 6 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07320469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing